CrystalGenomics
@cgxinc.com
CrystalGenomics is a structural chemoproteomics-based drug discovery and development company in Seoul, Korea.
CrystalGenomics's Company Logos
CrystalGenomics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#303030
Mine Shaft
48, 48, 48
0, 0, 19
0, 0, 0, 81
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#0B0B0B
Cod Gray
11, 11, 11
0, 0, 4
0, 0, 0, 96
About CrystalGenomics
CrystalGenomics is a global biotech company dedicated to improving the quality of life through innovative drug development. With the utilization of cutting-edge technology and a focus on diseases with high unmet medical needs, CrystalGenomics is at the forefront of research and development for groundbreaking new drugs. Their pipeline includes molecular-targeted anti-cancer agents that specifically target cancer cells, as well as novel drugs designed to address infectious diseases caused by unique microbial targets.
Additionally, CrystalGenomics is working towards developing drugs for inflammation and pain management. They collaborate with global pharmaceutical companies for technology exports and joint development, and their flagship product, Acelex, offers relief for symptoms of osteoarthritis. With a track record of published papers in prestigious journals and the listing of their technology as a bioventure special case, CrystalGenomics is recognized as a leader in the field of next-generation biopharmaceutical research and development
